Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-10-22 00:00:00 ET · period of report 2025-10-20 · accession 0001532218-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-22 | 2025-10-20+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $3.80 | +258.0K | 209.2K | New | +$980.3K |
| DM | 2025-10-22 | 2025-10-20+ | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $38.86 | -258.0K | 111.8K | -70% | -$10.02M |
| DM | 2025-10-22 | 2025-10-20+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -258.0K | 136.7K | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-10-20 | M | A | 121,248 | $3.80 | 233,042 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-10-20 | S | D | 98,934 | $38.81 | 134,108 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.14 and $39.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2025-10-20 | S | D | 22,314 | $39.32 | 111,794 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.14 and $39.55. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Ordinary Share | 2025-10-21 | M | A | 39,331 | $3.80 | 151,125 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2025-10-21 | S | D | 39,331 | $38.77 | 111,794 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.49 and $39.235. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2025-10-22 | S | D | 97,390 | $38.83 | 111,794 | D | — | — | (F5) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.495 and $39.255. The price reported in this column reflects a weighted sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 7 | Common | Class A Ordinary Share | 2025-10-22 | M | A | 97,390 | $3.80 | 209,184 | D | — | — | |
| 8 | Derivative | Share Option | 2025-10-21 | M | D | 39,331 | $0.00 | 97,390 | D | $3.80 · — to 2027-06-28 | 39,331 Class A Ordinary Share | (F6) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2025-10-22 | M | D | 97,390 | $0.00 | 0 | D | $3.80 · — to 2027-06-28 | 97,390 Class A Ordinary Share | (F6) The option is fully vested and exercisable. |
| 10 | Derivative | Share Option | 2025-10-20 | M | D | 121,248 | $0.00 | 136,721 | D | $3.80 · — to 2027-06-28 | 121,248 Class A Ordinary Share | (F6) The option is fully vested and exercisable. |